Doctor profile · Federal record
Dr. JOHN BETTERIDGE, M.D.
Gastroenterology Physician (CMS: GASTROENTEROLOGY) · LANCASTER, PA
- NPI 1447354410
- Accepts Medicare
- 22 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2112 HARRISBURG PIKE, SUITE 202
LANCASTER, PA 176012644
(717) 544-3500
fax (717) 544-3501 - Mailing address
-
2112 HARRISBURG PIKE STE 202
LANCASTER, PA 176012644
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- June 10, 2019
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Pennsylvania #MD453962
- Medicaid (3)
- PA #1029978880003 · PA #1029978880001 · PA #1029978880002
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447354410. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,502
Distinct HCPCS
10
Medicare allowed
$230,636
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 6,000 | 16 | $22 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 970 | 13 | $31 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 104 | 77 | $122 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 86 | 86 | $241 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 63 | 62 | $135 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 46 | 45 | $125 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | 39 | $87 | |
G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk | 37 | 36 | $167 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 29 | 23 | $68 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 23 | 18 | $62 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 197. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$76,116
Transactions
128
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 53 | $31,420.72 | |
| Janssen Biotech, Inc. | 31 | $29,790.68 | |
| PFIZER INC. | 22 | $14,402.77 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95.48 | |
| Ardelyx, Inc. | 4 | $84.87 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70.30 | |
| Celgene Corporation | 2 | $59.81 | |
| Lilly USA, LLC | 2 | $48.45 | |
| IRONWOOD PHARMACEUTICALS, INC | 2 | $27.69 | |
| Mallinckrodt Hospital Products Inc. | 1 | $25.99 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $24.58 | |
| Phathom Pharmaceuticals, Inc. | 1 | $24.13 | |
| CapsoVision, Inc. | 1 | $21.78 | |
| Boston Scientific Corporation | 1 | $18.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
583
Patients
111
Total drug cost
$3,010,906
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Omeprazole | Generic | 122 | 43 | $1,645 |
| Stelara (Ustekinumab) | Brand | 74 | 13 | $1,961,894 |
| Humira(Cf) Pen (Adalimumab) | Brand | 58 | 0 | $679,625 |
| Pantoprazole Sodium | Generic | 47 | 23 | $1,075 |
| Mesalamine | Generic | 43 | 13 | $30,281 |
| Mesalamine Er (Mesalamine) | Brand | 43 | 0 | $12,844 |
| Esomeprazole Magnesium | Generic | 34 | 19 | $1,467 |
| Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) | Brand | 28 | 0 | $692 |
| Xifaxan (Rifaximin) | Brand | 28 | 0 | $87,765 |
| Dicyclomine Hcl | Generic | 23 | 0 | $484 |